A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)
Status:
Completed
Trial end date:
2006-01-05
Target enrollment:
Participant gender:
Summary
Study will assess efficacy, safety and tolerability of brivaracetam in post-herpetic
neuralgia (PHN). Duration of 7 weeks divided into 3 periods with no up-titration, nor
down-titration.